FindTrial
Sign In

The mechanism of spatio-temporal regulation of Nrarp mediated by IGF2BP3, a novel m6A reader, in immune remolding of tumor-associated macrophages and the transformation of its clinical efficacy in triple negative breast cancer metastasis

The mechanism of spatio-temporal regulation of Nrarp mediated by IGF2BP3, a novel m6A reader, in immune remolding of tumor-associated macrophages and the transformation of its clinical efficacy in triple negative breast cancer metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037555
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Case series:triple negative breast cancer

Sponsors

Obstetrics and Gynecology Hospital affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Female; 2) Breast cancer.

Exclusion criteria

Exclusion criteria: Previous malignancies

Design outcomes

Primary

MeasureTime frame
IGF2BP3;—

Countries

China

Contacts

Public ContactMingdi Zhang

Obstetrics and Gynecology Hospital affiliated to Fudan University

mingdizhangoct@163.com+86 18901966020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026